Seizure |
Increased proinflammatory cytokine expression and BBB dysfunction |
Human/animal studies |
Three large-scale studies provided evidence for a positive association between T. canis seropositivity and seizure. |
71–73, 153–159, 200, 208
|
Schizophrenia |
Increased or decreased dopamine expression |
Animal studies |
Epidemiological studies indicated that the schizophrenia group had a higher seroprevalence of T. canis infection than healthy individuals. Increased or decreased dopamine expression was observed in the T. canis-infected mouse brain. |
97, 166–170, 173–178
|
Cognitive deficits |
CNS inflammation causes amyloid neuritic plaque formation |
Human/animal studies |
Several epidemiological studies indicated significant cognitive deficits in T. canis-seropositive children compared with seronegative controls. |
170, 179–189, 199
|
Idiopathic Parkinson's disease (IPD) |
CNS inflammation causes dopaminergic neuronal degeneration |
Animal studies |
Insignificantly higher seroprevalence of T. canis infection in patients with IPD than in controls. Significantly decreased GABA and DP levels were found in T. canis-infected mice compared with uninfected mice. |
170, 192–195
|
Dementia |
CNS inflammation causes amyloid neuritic plaque formation |
Human studies |
An elderly German woman with a long history of depression and cognitive decline showed reactive antibodies against T. canis antigen in CSF. |
75, 179, 180
|
Alzheimer's disease |
CNS inflammation causes amyloid neuritic plaque formation |
Human/animal studies |
Significantly increased proinflammatory cytokines and insoluble β-amyloid levels were found in brains of T. canis-infected mice compared with uninfected mice. |
170, 196, 200, 208
|